-
2022-500453-16-00
4
2023-10-30
Multiple Myeloma
-
2023-503582-35-00
6
2023-10-26
Staphylococcus aureus bacteremia
-
2024-517966-40-00
4
2023-07-13
Acute lymphoblastic leukemia (ALL), de novo, Ph/BCR::ABL1 positive (Ph
-
2024-511794-30-00
9
2023-06-28
Multiple Myeloma
-
2022-501187-18-00
5
2023-04-24
a. Diffuse large B-cell lymphoma (DLBCL) not otherwise specified (NOS)
-
2022-500783-35-00
5
2022-12-06
Acute Myeloid Leukemia
-
2022-500107-50-00
6
2022-10-12
hilar cholangiocarcinoma
-
2022-501180-40-00
5
2022-06-17
Ewing Sarcoma
-
2024-516504-42-00
5
2022-03-05
Respiratory distress syndrome in preterm infants
-
2024-510578-25-00
5
2021-11-05
Histologically proven high-risk medulloblastoma, with any of the curre
-
2024-510579-40-00
9
2020-10-07
Rhabdoyosarcoma
-
2024-518077-34-00
5
2020-09-30
locally advanced rectal cancer
-
2024-514494-21-00
4
2020-05-13
autoimmune encephalitis
-
2023-508926-91-00
5
2019-12-05
Stage IV childhood renal tumour with pulmonary +/- non-pulmonary
metas
-
2023-508101-24-00
5
2019-08-01
Lymphoblastic lymphoma
-
2024-512222-28-00
10
2015-06-02
Newly diagnosed with an intracranial or spinal ependymoma (all WHO gra
-
2025-521067-13-00
5
2026-04-24
Atherosclerotic Cardiovascular Disease (ASCVD)
-
2025-520521-21-00
5
2025-09-02
Hyperlipidemia
-
2024-514064-17-00
3
2025-05-23
Pulmonary Arterial Hypertension
-
2024-512946-41-00
5
2025-03-05
Menstrual Migraine
-
2024-512720-11-00
5
2025-01-16
chronic venous ulcers (CVU)
-
2022-501457-37-00
5
2024-10-28
Myeloid Leukemia in Children with Down Syndrome
-
2023-507851-31-00
5
2024-09-23
Immunoglobulin A Nephropathy (IgAN)
-
2023-503923-24-00
5
2024-07-22
Sjögren’s Syndrome With Moderate-toSevere Symptom State